Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries’ wholly-owned Subsidiary -- Sun Pharma (Netherlands) B.V. has signed a binding letter of intent to acquire the balance 25% outstanding shares of Sun Pharma de Mexico, S.A. de C.V., a subsidiary of the Company, where the Company is currently holding 75% shares.

Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de Mexico, S.A. de C.V. becoming a wholly-owned subsidiary of the Company.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.